8SOS
Human CD1d presenting sphingomyelin C24:1 in complex with VHH nanobody 1D17
Summary for 8SOS
Entry DOI | 10.2210/pdb8sos/pdb |
Descriptor | Antigen-presenting glycoprotein CD1d, Beta-2-microglobulin, Nanobody VHH ID17, ... (6 entities in total) |
Functional Keywords | cd1d, sphingomyelin, nkt, nanobody, vhh, 1d17, immune system |
Biological source | Homo sapiens (human) More |
Total number of polymer chains | 6 |
Total formula weight | 132974.47 |
Authors | Shahine, A.,Rossjohn, J. (deposition date: 2023-04-29, release date: 2023-12-13, Last modification date: 2024-10-30) |
Primary citation | Lameris, R.,Shahine, A.,Veth, M.,Westerman, B.,Godfrey, D.I.,Lutje Hulsik, D.,Brouwer, P.,Rossjohn, J.,de Gruijl, T.D.,van der Vliet, H.J. Enhanced CD1d phosphatidylserine presentation using a single-domain antibody promotes immunomodulatory CD1d-TIM-3 interactions. J Immunother Cancer, 11:-, 2023 Cited by PubMed Abstract: CD1d is a monomorphic major histocompatibility complex class I-like molecule that presents lipid antigens to distinct T-cell subsets and can be expressed by various malignancies. Antibody-mediated targeting of CD1d on multiple myeloma cells was reported to induce apoptosis and could therefore constitute a novel therapeutic approach. PubMed: 38040419DOI: 10.1136/jitc-2023-007631 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.33 Å) |
Structure validation
Download full validation report